Low Dose Aspirin Can Prevent The Breast Cancer: It is Fresh updating News about health. The regular use of Low-dose “Aspirin”  may reduce the risk of breast cancer in women.

Low Dose Aspirin Can Prevent The Breast Cancer

Low-Dose Aspirin Can Prevent The Breast Cancer
Low-Dose Aspirin Can Prevent The Breast Cancer

According to new research,  women who took low-dose aspirin daily were at lower risk of developing breast cancer. The researchers found that among more than 130,000U.S. adults, those who regularly used aspirin were 7% to 11% less likely to die of cancer over the next few decades. Low-Dose Aspirin is fighting

Low-Dose Aspirin is fighting To Decrease Cancer: Low Dose Aspirin Can Prevent The Breast Cancer

The Researchers also find that the aspirin has cancer-fighting abilities, But they also accepted that people should not begin popping a daily aspirin in the hopes of avoiding cancer. In General, that little quantity aspirin may reduce the danger of colon cancer, said Professor Dr. Ernest Hawk at the University of Texas M.D. Anderson Cancer Center in Houston.

The USPSTF (U.S. Preventive Services Task Force)  already suggests that some older adults are taking low-dose aspirin to control their risk of colon cancer as well as heart disease.

Specifically, the task force advises to the people in their 50s and 60s talk to their doctor about whether the advantages of daily aspirin outweigh the risks. The USPSTF is an independent medical panel that advises the federal government.

However, the FDA was concerned that some patients, particularly those 60 and older, face an increased risk of stroke and bleeding—both gastrointestinal and in the brain—if they take aspirin daily. However, this study was not a prospective one and was derived from observations done by different sets of examiners at different times and with different entry criteria and is not as reliable as the Southampton study.

Also Read: What is Bladder Cancer? Ways to Cure Via Immunotherapies and Current Research and Bladder Cancer Treatment

“This is the initial report to suggest the reduction in risk occurs for the small quantity of aspirin and not for regular-dose and only among women with the hormone receptor-positive/HER2-negative subtype,” wrote the study’s authors. “This preliminary survey builds on previous knowledge and further supports the need for formal cancer chemoprevention studies of low-dose aspirin.”  They suggest that anyone adding aspirin to their daily regimen first consult a primary care physician.

Follow us on Phonemantra

LEAVE A REPLY

Please enter your comment!
Please enter your name here